TR200102877T2 - İmmünoglobulinin kendi yüksek afinite reseptörüne bağlanmasını inhibe eden antikorlara karşı anti-idiotipik antikorlar. - Google Patents

İmmünoglobulinin kendi yüksek afinite reseptörüne bağlanmasını inhibe eden antikorlara karşı anti-idiotipik antikorlar.

Info

Publication number
TR200102877T2
TR200102877T2 TR2001/02877T TR200102877T TR200102877T2 TR 200102877 T2 TR200102877 T2 TR 200102877T2 TR 2001/02877 T TR2001/02877 T TR 2001/02877T TR 200102877 T TR200102877 T TR 200102877T TR 200102877 T2 TR200102877 T2 TR 200102877T2
Authority
TR
Turkey
Prior art keywords
binding
immunoglobulin
inhibit
affinity receptor
high affinity
Prior art date
Application number
TR2001/02877T
Other languages
English (en)
Inventor
Kricek Franz
Stadler Beda
Vogel Monique
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of TR200102877T2 publication Critical patent/TR200102877T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4208—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
    • C07K16/4241—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/55—Fab or Fab'

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Otolaryngology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

IgE C3 bölgesinin kendi afinite reseptörüne (mimobodiler, mimobodies) baglanmasina müdahale eden bir antikora ve özellikle BSW17'ye (BSW17-mimobodileri) karsi anti-idiotipik olan antikorlar ve antikor fragmanlari ve ayrica bunlarin IgE aracilikli hastaliklarda farmasötik ve özellikle asi olarak kullanilmalari tarif edilmistir. (Sekil 1)
TR2001/02877T 1999-04-14 2000-04-12 İmmünoglobulinin kendi yüksek afinite reseptörüne bağlanmasını inhibe eden antikorlara karşı anti-idiotipik antikorlar. TR200102877T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9908533.4A GB9908533D0 (en) 1999-04-14 1999-04-14 Organic compounds

Publications (1)

Publication Number Publication Date
TR200102877T2 true TR200102877T2 (tr) 2002-01-21

Family

ID=10851525

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2001/02877T TR200102877T2 (tr) 1999-04-14 2000-04-12 İmmünoglobulinin kendi yüksek afinite reseptörüne bağlanmasını inhibe eden antikorlara karşı anti-idiotipik antikorlar.

Country Status (29)

Country Link
US (1) US7041288B2 (tr)
EP (1) EP1169353B1 (tr)
JP (1) JP4109829B2 (tr)
KR (1) KR100492202B1 (tr)
CN (1) CN1268644C (tr)
AR (1) AR029624A1 (tr)
AT (1) ATE392437T1 (tr)
AU (1) AU767712B2 (tr)
BR (1) BR0009781A (tr)
CA (1) CA2363991C (tr)
CO (1) CO5241329A1 (tr)
CZ (1) CZ20013673A3 (tr)
DE (1) DE60038608T2 (tr)
ES (1) ES2302693T3 (tr)
GB (1) GB9908533D0 (tr)
HK (1) HK1044544B (tr)
HU (1) HUP0200713A2 (tr)
IL (2) IL145507A0 (tr)
MX (1) MXPA01010348A (tr)
MY (1) MY141459A (tr)
NO (1) NO20014936L (tr)
PE (1) PE20010046A1 (tr)
PL (1) PL350676A1 (tr)
PT (1) PT1169353E (tr)
RU (1) RU2253655C2 (tr)
SK (1) SK14592001A3 (tr)
TR (1) TR200102877T2 (tr)
WO (1) WO2000063252A1 (tr)
ZA (1) ZA200107906B (tr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6913749B2 (en) 1998-11-02 2005-07-05 Resistentia Pharmaceuticals Ab Immunogenic polypeptides for inducing anti-self IgE responses
GB0103174D0 (en) * 2001-02-08 2001-03-28 Smithkline Beecham Plc Novel method of treatment
EP1239032A1 (en) 2001-03-02 2002-09-11 Société des Produits Nestlé S.A. Lactic acid bacteria as agents for treating and preventing allergy
SE0101093D0 (sv) * 2001-03-28 2001-03-28 Pharmacia Diagnostics Ab Novel compound for treatment of allergy and asthma
EP1497654A4 (en) 2001-08-13 2006-06-07 Chen Swey Shen Alex IMMUNOGLOBULIN E VACCINES AND METHODS OF USE
TWI323265B (en) 2002-08-06 2010-04-11 Glaxo Group Ltd Antibodies
GB0306309D0 (en) 2003-03-19 2003-04-23 Glaxo Group Ltd Method of treatment
US8029783B2 (en) * 2005-02-02 2011-10-04 Genentech, Inc. DR5 antibodies and articles of manufacture containing same
CN101062949B (zh) * 2006-04-26 2011-07-27 上海抗体药物国家工程研究中心有限公司 重组抗人IgE单克隆抗体及其制备方法和用途
US20080118524A1 (en) * 2006-10-20 2008-05-22 Stefan Persson Anti-IgE Vaccines
UA95329C2 (ru) * 2006-12-14 2011-07-25 Шеринг-Плау Лтд. Собачий тимусный стромальный лимфопоэтин и его применение
ES2670576T3 (es) * 2009-09-03 2018-05-31 Pfizer Vaccines Llc Vacuna de PCSK9
LT3023438T (lt) 2009-09-03 2020-05-11 Merck Sharp & Dohme Corp. Anti-gitr antikūnai
US10214593B2 (en) 2013-04-02 2019-02-26 Samsung Electronics Co., Ltd. Anti-idiotype antibody against anti-c-MET antibody
BR112021016791A2 (pt) * 2019-02-26 2021-11-16 Sorrento Therapeutics Inc Proteínas de ligação de antígenos que se ligam a bcma

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
ATE45285T1 (de) 1983-11-07 1989-08-15 Wistar Inst Durch antiidiotype antikoerper induzierte immune antwort zu tumoren und viren.
CA1341235C (en) 1987-07-24 2001-05-22 Randy R. Robinson Modular assembly of antibody genes, antibodies prepared thereby and use
AU618317B2 (en) * 1987-12-31 1991-12-19 Tanox Biosystems, Inc. Unique antigenic epitopes on ige-bearing b lymphocytes
CA2074089C (en) 1990-01-23 2001-04-10 Tse-Wen Chang Extracellular segments of human e immunoglobulin anchoring peptides and antibodies specific therefor
IT1238286B (it) 1990-03-26 1993-07-12 Dispositivo sensore di livello del liquido per caldaie a vapore.
US5512283A (en) 1990-07-06 1996-04-30 Allergene, Inc. Methods for the selective suppression of an immune response to dust mite der Pi
AU681360B2 (en) 1992-09-30 1997-08-28 Scripps Research Institute, The Human neutralizing monoclonal antibodies to human immunodeficiency virus
HUP9901109A3 (en) * 1996-03-01 1999-11-29 Novartis Ag Peptide immunogens for vaccination against and treatment of allergy
JPH11174A (ja) * 1997-06-13 1999-01-06 Asahi Breweries Ltd 酵母を用いた抗体Ｆａｂ断片の製造法
US5994511A (en) 1997-07-02 1999-11-30 Genentech, Inc. Anti-IgE antibodies and methods of improving polypeptides
AU762711C (en) 1998-04-24 2004-05-27 Fang Fang Identifying peptide ligands of target proteins with target complementary library technology (TCLT)

Also Published As

Publication number Publication date
KR20020007366A (ko) 2002-01-26
CA2363991A1 (en) 2000-10-26
CN1268644C (zh) 2006-08-09
CO5241329A1 (es) 2003-01-31
ZA200107906B (en) 2003-08-27
GB9908533D0 (en) 1999-06-09
WO2000063252A1 (en) 2000-10-26
BR0009781A (pt) 2002-01-08
AU767712B2 (en) 2003-11-20
PL350676A1 (en) 2003-01-27
ATE392437T1 (de) 2008-05-15
JP2002544125A (ja) 2002-12-24
EP1169353A1 (en) 2002-01-09
SK14592001A3 (sk) 2002-05-09
AU3966000A (en) 2000-11-02
KR100492202B1 (ko) 2005-06-03
JP4109829B2 (ja) 2008-07-02
CA2363991C (en) 2010-06-08
IL145507A (en) 2008-11-03
IL145507A0 (en) 2002-06-30
AR029624A1 (es) 2003-07-10
PT1169353E (pt) 2008-07-14
EP1169353B1 (en) 2008-04-16
RU2253655C2 (ru) 2005-06-10
HK1044544A1 (en) 2002-10-25
NO20014936D0 (no) 2001-10-10
DE60038608D1 (de) 2008-05-29
US20020141989A1 (en) 2002-10-03
NO20014936L (no) 2001-12-03
ES2302693T3 (es) 2008-08-01
HUP0200713A2 (en) 2002-07-29
MXPA01010348A (es) 2002-10-23
US7041288B2 (en) 2006-05-09
PE20010046A1 (es) 2001-02-23
CN1346372A (zh) 2002-04-24
MY141459A (en) 2010-04-30
CZ20013673A3 (cs) 2002-05-15
HK1044544B (zh) 2008-11-21
DE60038608T2 (de) 2009-06-10

Similar Documents

Publication Publication Date Title
TR200102877T2 (tr) İmmünoglobulinin kendi yüksek afinite reseptörüne bağlanmasını inhibe eden antikorlara karşı anti-idiotipik antikorlar.
ES2293973T3 (es) Anticuerpos anti-ccr2 humanizados y metodos de uso de los mismos.
CR8231A (es) Anticuerpos rg1 y uso de los mismos
DE60142342D1 (de) Antikörper gegen doppelintegrinen, zusammensetzungen, verfahren und verwendungen
ES2137354T3 (es) Moleculas de anticuerpo anti-vla4 recombinante.
TR200003181T2 (tr) Gelişmiş çoğaltılabilirliğe sahip FAP alfa'ya özgü antikor
HK1074670A1 (en) Sets of digital antibodies directed against short epitopes, and methods using same
HK1048477A1 (zh) 卵巢的癌細胞及骨髓癌細胞使糖蛋白浮現，它的抗體及其使用
WO2001090358A3 (en) Mammalian receptor proteins; related reagents and methods
NZ333329A (en) Polypeptides capable of forming antigen binding structures with specificity for rhesus d antigens
EP1433792A8 (en) Human receptor proteins, related reagents and methods
WO2001036467A3 (en) Mammalian receptor proteins; related reagents and methods
DE60129278D1 (de) Gegen das SEMP1-Protein gerichtete Antikörper, Verfahren zu deren Herstellung, und deren Anwendungen
WO1999046379A3 (en) Human receptor proteins; related reagents and methods
ATE171473T1 (de) Humanisierte monoklonale antikörper gegen humanes interleukin - 4
ATE248189T1 (de) Antikörper gegen vasp (vasodilator-stimulated phosphoprotein), hybridomzellen für deren gewinnung, und deren verwendung
DE69938725D1 (de) Monoklonale antikörper gegen das protein g3bp und deren verwendungen
DE60141297D1 (de) Gegen das menschliche bst2 antigen gerichteter monoklonaler antikörper
WO2001057219A3 (en) Mammalian interleukin-1-delta and -epsilon. their use in therapeutic and diagnostic methods
DE69115104D1 (de) Composition comprising at least two different antibodies or fragments thereof.
PT723552E (pt) Oligopeptidos derivados de fragmentos de proteina reactiva c
ATE189897T1 (de) Antikörper gegen das prorenin profragment, reninaktive substanz die diese enthält und prorenintest die diese verwendet
WO1999019480A3 (en) Human receptor proteins; related reagents and methods
WO2000017363A3 (en) Interleukin-1 like molecule: interleukin-1-zeta; nucleic acids, polypeptides, antibodies, their uses
ATE525086T1 (de) Antikörper gegen thyrotropinrezeptor und ihre verwendungen